Search research articles
Contact Us
Filters
Showing results (251-260 of 607) with videos related to
Page
of 61
Sort By:
Clinical and Experimental Rheumatology
|
August 4, 2025
Impact of immunosuppression on development and outcome of systemic sclerosis-associated pulmonary arterial hypertension
Stefano Rodolfi, Cheryl Chun Man Ng, Ana Maria Ruiz Bejerano, et al.
The European Respiratory Journal
|
August 29, 2024
Definition, classification and diagnosis of pulmonary hypertension
Gabor Kovacs, Sonja Bartolome, Christopher P Denton, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
September 19, 2022
Dynamic Prediction of Pulmonary Hypertension in Systemic Sclerosis Using Landmark Analysis
Svetlana I Nihtyanova, Benjamin E Schreiber, Voon H Ong, et al.
British Journal of Rheumatology
|
February 1, 1997
Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis
C P Denton, J B Cailes, G D Phillips, et al.
Annals of the Rheumatic Diseases
|
January 17, 2012
Demographic, clinical and antibody characteristics of patients with digital ulcers in systemic sclerosis: data from the DUO Registry
Christopher P Denton, Thomas Krieg, Loic Guillevin, et al.
Rheumatology (Oxford, England)
|
September 19, 2001
Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine
B Coleiro, S E Marshall, C P Denton, et al.
Annals of the Rheumatic Diseases
|
November 18, 2004
The myth of pulmonary Raynaud's phenomenon: the contribution of pulmonary arterial vasospasm in patients with systemic sclerosis related pulmonary arterial hypertension
D Mukerjee, L B Yap, V Ong, et al.
Arthritis and Rheumatism
|
April 1, 2006
Contribution of activin receptor-like kinase 5 (transforming growth factor beta receptor type I) signaling to the fibrotic phenotype of scleroderma fibroblasts
Yunliang Chen, Xu Shi-wen, Mark Eastwood, et al.
QJM : Monthly Journal of the Association of Physicians
|
December 8, 2009
Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study
S I Nihtyanova, E C Tang, J G Coghlan, et al.
British Journal of Pharmacology
|
June 1, 1978
Levels of prostaglandins and their precursors in EFA-deficient rabbits--a new concept of prostaglandin biosynthesis [proceedings]
M A Crawford, J P Denton, A G Hassam, et al.
Page
of 61
Search research articles
Search
Showing results (251-260 of 607) with videos related to
Sort By:
Page
of 61
Clinical and Experimental Rheumatology
|
August 4, 2025
Impact of immunosuppression on development and outcome of systemic sclerosis-associated pulmonary arterial hypertension
Stefano Rodolfi, Cheryl Chun Man Ng, Ana Maria Ruiz Bejerano, et al.
The European Respiratory Journal
|
August 29, 2024
Definition, classification and diagnosis of pulmonary hypertension
Gabor Kovacs, Sonja Bartolome, Christopher P Denton, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
September 19, 2022
Dynamic Prediction of Pulmonary Hypertension in Systemic Sclerosis Using Landmark Analysis
Svetlana I Nihtyanova, Benjamin E Schreiber, Voon H Ong, et al.
British Journal of Rheumatology
|
February 1, 1997
Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis
C P Denton, J B Cailes, G D Phillips, et al.
Annals of the Rheumatic Diseases
|
January 17, 2012
Demographic, clinical and antibody characteristics of patients with digital ulcers in systemic sclerosis: data from the DUO Registry
Christopher P Denton, Thomas Krieg, Loic Guillevin, et al.
Rheumatology (Oxford, England)
|
September 19, 2001
Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine
B Coleiro, S E Marshall, C P Denton, et al.
Annals of the Rheumatic Diseases
|
November 18, 2004
The myth of pulmonary Raynaud's phenomenon: the contribution of pulmonary arterial vasospasm in patients with systemic sclerosis related pulmonary arterial hypertension
D Mukerjee, L B Yap, V Ong, et al.
Arthritis and Rheumatism
|
April 1, 2006
Contribution of activin receptor-like kinase 5 (transforming growth factor beta receptor type I) signaling to the fibrotic phenotype of scleroderma fibroblasts
Yunliang Chen, Xu Shi-wen, Mark Eastwood, et al.
QJM : Monthly Journal of the Association of Physicians
|
December 8, 2009
Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study
S I Nihtyanova, E C Tang, J G Coghlan, et al.
British Journal of Pharmacology
|
June 1, 1978
Levels of prostaglandins and their precursors in EFA-deficient rabbits--a new concept of prostaglandin biosynthesis [proceedings]
M A Crawford, J P Denton, A G Hassam, et al.
Page
of 61